Member Info for Aldebaran

It seems to me Myles has ramped most of you in just to early. 200dma rolling over and price breaking and closing below it tell me the hopium keeping this balloon flying is all escaping.

Biggest concern is cash I still cant understand how they are going to list on NASDAQ without a very lofty raise.

Beneath the optimism lies a company that remains in build-out mode—consuming cash, generating only modest revenue, and depending on future financing, government support, and successful execution across multiple ambitious projects.

Thought the placing was supposedly to quality institutions? Clearly whoever it is is flipping so im struggling to belief this at the moment.

Ok Jezza yes, owning 100% of IP is good also. Like I say I am prepared to acknowledge and point out the good points about HEMO. Technically price is holding up well above 200wma as well. Not bullish yet but as I said recently it appears the selling is done (at least for now).

Hard to imagine anything which would cause this to go lower in short term now so for a trade the risk reward looks good. Stop below recent low and upside could go anywhere as it will be driven by sentiment of p4 injection. One would expect anyway.

So their you go my ramping done 😂

Im far from convinced of long term yet but 28day safety review of p4 could change the risk reward profile once again, if favourable.

Of course it is a appropriate measure of valuation. Im not talking of P/E ratio or free cashflow to EBITDA or whatever. I understand this is a loss maker but it is generating revenue i.e. sales therefore a price/sales multiple seems entirely perfect. You have a better way im all ears?

Also, is the reason nobody is providing sales figures projections because you dont know them or are embarrassed by them?

LTL fair assessment lol

Yes maybe I am too negative and distrusting. Im battle scarred after years of trying to invest in smallcaps.

I have said a few positive things about hemo. I do believe and have proved through my calculations (right or wrong), that it is undervalued. I do believe the science is promising. I do think the low share count (if it stays that way) is a great plus point and their is very large upside.

Ill end it there

So almost 200m market cap and projected revenues of not even 1.5m from the fuel cell side of the business since 31st Oct is financial year end. Can anyone confirm the other sales projections (hydrogen off takes or anything).

For a 200m valuation I'd be generous and put it on a Price to Sales of 25 meaning would want to see minimum of 8m revenue for this year and needs to be growing.

Is that being achieved or is it planned?

This year for 2026 what exactly are Hpow expecting to generate can anyone remind me please.

I have 1.5m assuming we sell the 15 LC 30's for 100k a pop but then what else?

Thanks

Their is always a sell of after avacta releases data because traders only in for commercial stuff which is fine they dont understand science of it all.

What i am seeing time after time after the sell of is a rally to new high indicating delayed response to the good news. Like people who do get it just wait a day or 2 for price to fall then pick up the cheapies

LTL I agree, funding done and no immediate risks. Im just reading that presentation deck and I am raising a concern for discussion and suggesting it MAY be a reason why recruitment is slow.

Its fine to debate that right or do we have to put a positive slant on everything just because to many people here are over emotionally and financially invested?

Im wondering whether this serious adverse event is what is putting a dampener on recruitment. I know you all think otherwise and farmer are queuing up with blank checks and oncologists are banging vlads door down to get patients on the trial but if that turns out to be untrue... hmmmm

Dont overexpose folks. Not with just 1 shot on goal and only 3 patience treated so far. Seriously I mean it. Something seems a bit off to me. If this was truly groundbreaking then no way recruitment would be taking this long

Thanks for sharing this. If anything it SCREAMS early days to me which is fine but for you guys claiming its on the verge of a mega money buyout then your head is in the clouds to be frank. Phase 2 wont start for another 12-24 months and thats IF it starts. Looking at the Phase 1 results which I remind you is the lowest dose treating just 3 patience and there have been

36 adverse events

2 directly related to the treatment

1 of those considered serious

No DLT's of course but they could easily pop up once the dose is increased and its game over for HG-CT-1.

How serious was this serious adverse event and how close was it to becoming a DLT I wonder?

With price falling through the 200dma on volume id be cautious still. Last time price hit this low there was a HUGE volume spike and their was significant volume/price divergence indicating a lot of offloading of stock. See this heading 78-84p range myself and with oil rising, dollar looking stronger it seems to me gold will continue to slide which will effect sentiment. I know its bearish and dont shoot me its just my opinion. Maybe wrong. Good luck to you all.

Avacta has 500 shots on goal. Whats the odds 1 of them hits the back of the net?

Because that's all we need to win. Then its just a matter of how many multiples on top of that we get.

HEMO was 1000p a few weeks back, on same day Avacta did a placing at 63p. Today Hemo is at 700 and Avacta at 75p. You might want to check those timestamps again HFH

My average is 52p, the scientific results today were remarkable as you'd know if you read them and understood them. The market sold off as was expecting a commercial deal to be announced, as it happens, its most likely to be at Spring BIO end of June now with release of breast cancer data. 4 weeks is a long time to wait for an AIM share isn't it 😅

And if any company in small cap land knows all about how scientific achievements aren't valued properly its HEMO. Ive said and proven a few times its undervalued.

Ultimately both companies are undervalued but Avacta is by far the superior overall investment. I know this because I've researched both properly where as you and the other low IQ HEMOngs haven't.

Ok, ill unblock teabag just so I can report every one of his posts. Recommend this post if your doing the same. Let's make a pact and clean up this BB.

Once again a fantastic day of science overshadowed by talks with and about the trolls. It needs to end and we need to end it

So they weren't committed when they had original options?

Would they not be equally committed having them at a higher strike price or linked to any kind of performance?

Barely any critical analysis on this board. You all believe because you want to believe and your wealth is being eroded day by day.

As ive said before its not all about the science and there are much better investments available that tick all boxes.

Options are ok and I think some kind of share scheme for employees is good as well but the timing, quantity and price of these ones is outrageous. The BOD have utterly destroyed people's accounts here over the years and now just help themself to 20% of the company. Its criminal. They should keep existing options and if they want more shares then buy in open market or take part in the last placing.

But its done. Either sell up or shut up now I guess.

Erm....

The simple and obvious answer is that they are struggling to recruit. I dont know this as a fact but have you even stopped to consider that actually after the 28 day safety review that a few months down the line disease came back and maybe even more aggressively? Ok it MAY work at a higher strength sure but if the above is true then you wouldn't be rushing to get on the trial would you.

Problem here is you all just assume positive reasons for the radio silence when in my experience its usually that no news is bad news in small caps with sh i t e CEO's like this.

Promising but very early science.